FDA Drug Approvals - Search News

FDA, Mirum and Pharmaceuticals

US FDA approves Mirum Pharma's genetic disorder drug

The U.S. Food and Drug Administration approved Mirum Pharmaceuticals' genetic disorder drug on Friday, making it the first treatment for a rare condition that interferes with the body's ability to process cholesterol.

The Hill · 10d

FDA approves new genetic disorder drug

The Food and Drug Administration (FDA) approved a new drug to treat a disorder causing the growth of noncancerous tumors on nerves throughout the body. The federal agency said on Tuesday it

MarketWatch · 15h

FDA Approves Mirum Pharmaceuticals Treatment for Lipid-Storage Disease

The Food and Drug Administration approved Mirum Pharmaceuticals' Ctexli to treat Cerebrotendinous Xanthoma, a very rare lipid-storage disease. The approval makes Ctexli, or chenopod, the first FDA-approved drug to treat CTX, the agency said Friday.

Healio · 11h

FDA approves first treatment for rare lipid storage disease

The FDA has approved Ctexli for the treatment of cerebrotendinous xanthomatosis (CTX), a rare lipid storage disease, in adults.According to a press release, Ctexli (chenodiol) is the first FDA-approved drug to treat CTX.

Business Insider · 16h

FDA approves Mirum treatment for cerebrotendinous xanthomatosis

The Food and Drug Administration approved Ctexli for the treatment of cerebrotendinous xanthomatosis in adults. “Ctexli is the first

Ozempic and Wegovy, FDA

The Washington Post on MSN · 13h

FDA says Ozempic shortage is over, chilling boom in off-brand versions

The FDA has now resolved the shortages of Novo Nordisk’s and Eli Lilly’s blockbuster weight-loss drugs, which could spell the end to the booming market for cheaper versions made by pharmacies.

The Hill on MSN · 12h

Ozempic and Wegovy officially moved off FDA’s drug shortage list

Ozempic and Wegovy, the widely popular forms of semaglutide sold to treat diabetes and obesity, have officially been removed from the Food and Drug Administration’s (FDA) drug shortage list

CNN on MSN · 15h

Ozempic and Wegovy are no longer in shortage, FDA says

Blockbuster weight-loss and diabetes drugs Wegovy and Ozempic are no longer in shortage, the US Food and Drug Administration said on Friday.

JD Supra19h

FDA Layoffs, RFK Jr. at HHS, and What This Means for FDA-Regulated Companies

In recent weeks, the FDA has faced significant cuts, including the layoffs of probationary employees. These employees, many ...

14m

Children with autism may see speech improvements with off-label prescription drug

An off-label prescription drug has been shown to help children with autism gain the ability to speak. Leucovorin is used for ...

FiercePharma14h

After asset purchase from Travere, Mirum's Ctexli crosses FDA finish line in rare metabolic disorder

The approval makes chenodiol—already cleared for decades to treat radiolucent gallstones under the brand name Chenodal—the ...

1don MSN

OnePlus seeks FDA approval for Sleep Apnea Detection on its watch and takes on Apple in the process

OnePlus is hoping the OnePlus Watch 3 could get FDA approval for its new sleep apnea detection feature, bringing it one step ...

FDA approves first rapid-acting insulin biosimilar for patients with diabetes

Aventis's Merilog (insulin-aspart-szjj) as a biosimilar to Novolog (insulin aspart) for adults and pediatric patients with ...

Science Friday4d

The FDA Approves A New, Non-Opioid Painkiller

Here to help break down this new painkiller is Dr. Sean Mackey. He’s a Professor of Anesthesiology and Medicine at Stanford ...

News Medical on MSN1d

Vimseltinib gains FDA approval for treating tenosynovial giant cell tumor

The U.S. Food and Drug Administration (FDA) has approved vimseltinib (Romvimza TM ) for adult patients with a rare condition ...

4don MSN

Teva Pharm CEO calls on Trump for faster US drug approvals

U.S. President Donald Trump's administration needs to speed up generic drug approvals and exempt some drugs from funding ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results